These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

477 related items for PubMed ID: 16326745

  • 1. Anticoagulant-free Genius haemodialysis using low molecular weight heparin-coated circuits.
    Frank RD, Müller U, Lanzmich R, Groeger C, Floege J.
    Nephrol Dial Transplant; 2006 Apr; 21(4):1013-8. PubMed ID: 16326745
    [Abstract] [Full Text] [Related]

  • 2. Optimal anticoagulation strategy in haemodialysis with heparin-coated polyacrylonitrile membrane.
    Lavaud S, Canivet E, Wuillai A, Maheut H, Randoux C, Bonnet JM, Renaux JL, Chanard J.
    Nephrol Dial Transplant; 2003 Oct; 18(10):2097-104. PubMed ID: 13679486
    [Abstract] [Full Text] [Related]

  • 3. [Prevention of thrombogenesis in the extracorporeal circuit of hemodialysis with a low molecular heparin: standardization of the dosage with a better hemorrhagic risk/effectiveness ratio].
    Barata JD, Oliveira C, Bruges M, Gusmão L, Santana A, Ponce P, Simões J, Freire I, Crespo F, da Silva AN.
    Acta Med Port; 1992 Feb; 5(2):65-70. PubMed ID: 1317657
    [Abstract] [Full Text] [Related]

  • 4. The clinical evaluation of low-dose heparin in haemodialysis: a prospective study using the heparin-coated AN69 ST membrane.
    Chanard J, Lavaud S, Maheut H, Kazes I, Vitry F, Rieu P.
    Nephrol Dial Transplant; 2008 Jun; 23(6):2003-9. PubMed ID: 18156457
    [Abstract] [Full Text] [Related]

  • 5. Factor Xa-activated whole blood clotting time (Xa-ACT) for bedside monitoring of dalteparin anticoagulation during haemodialysis.
    Frank RD, Brandenburg VM, Lanzmich R, Floege J.
    Nephrol Dial Transplant; 2004 Jun; 19(6):1552-8. PubMed ID: 15034159
    [Abstract] [Full Text] [Related]

  • 6. [Minimal heparinization in dialysis patients with increased risk of bleeding].
    Klingel R, Wandel E, Hafner G, Meyer zum Büschenfelde KH, Köhler H.
    Dtsch Med Wochenschr; 1993 Dec 23; 118(51-52):1878-83. PubMed ID: 8287777
    [Abstract] [Full Text] [Related]

  • 7. Low molecular weight heparin and haemodialysis: neutralization by protaminchloride.
    Andrassy K.
    Blood Coagul Fibrinolysis; 1993 Dec 23; 4 Suppl 1():S39-43. PubMed ID: 8180328
    [Abstract] [Full Text] [Related]

  • 8. [Appropriate dosage of unfraction heparin and low molecular weight heparin in hemodialysis patients].
    Xiao Q, Sun XF, Zhang D, Ma ZF, Wu MG, Wang H, Chen XM.
    Zhonghua Yi Xue Za Zhi; 2010 Jan 19; 90(3):187-91. PubMed ID: 20356555
    [Abstract] [Full Text] [Related]

  • 9. Intermittent saline flushes during haemodialysis do not alleviate coagulation and clot formation in stable patients receiving reduced doses of dalteparin.
    Sagedal S, Hartmann A, Osnes K, Bjørnsen S, Torremocha J, Fauchald P, Kofstad J, Brosstad F.
    Nephrol Dial Transplant; 2006 Feb 19; 21(2):444-9. PubMed ID: 16234293
    [Abstract] [Full Text] [Related]

  • 10. The AN69 ST haemodialysis membrane under conditions of two different extracorporeal circuit rinse protocols a comparison of thrombogenicity parameters.
    Richtrova P, Opatrny K, Vit L, Sefrna F, Perlik R.
    Nephrol Dial Transplant; 2007 Oct 19; 22(10):2978-84. PubMed ID: 17597089
    [Abstract] [Full Text] [Related]

  • 11. Comparison of two heparin-coated extracorporeal circuits with reduced systemic anticoagulation in routine coronary artery bypass operations.
    Ovrum E, Tangen G, Oystese R, Ringdal MA, Istad R.
    J Thorac Cardiovasc Surg; 2001 Feb 19; 121(2):324-30. PubMed ID: 11174738
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Review: anticoagulation for haemodialysis.
    Suranyi M, Chow JS.
    Nephrology (Carlton); 2010 Jun 19; 15(4):386-92. PubMed ID: 20609088
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. A single bolus of a low molecular weight heparin to patients on haemodialysis depletes lipoprotein lipase stores and retards triglyceride clearing.
    Näsström B, Stegmayr B, Gupta J, Olivecrona G, Olivecrona T.
    Nephrol Dial Transplant; 2005 Jun 19; 20(6):1172-9. PubMed ID: 15797889
    [Abstract] [Full Text] [Related]

  • 17. [Preparation and antithrombogenicity of oxidated low molecular weight heparin-antithrombin complex coated-polyvinyl chloride tubing].
    Luo P, Liu W, Yang C, Zhou H, Cao R, Yang J.
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2011 Feb 19; 28(1):90-4. PubMed ID: 21485191
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Evaluation of coagulation and anti-Xa factor when using a heparin-coated AN69ST® dialyser.
    Sánchez-Canel JJ, Pons-Prades R, Salvetti ML, Seores A, Vázquez M, Pérez-Alba A, Tamarit E, Calvo-Gordo C, Villatoro J.
    Nefrologia; 2012 Feb 19; 32(5):605-12. PubMed ID: 23013946
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.